The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Increased Prevalence of Impaired Glucose Tolerance in Patients With Painful Sensory Neuropathy
Open accessAbstract
OBJECTIVE—To characterize a cohort of patients with neuropathy and impaired glucose tolerance (IGT) but no other identifiable cause of neuropathy. Of patients with diabetes, 10% have peripheral neuropathy at the time of their diagnosis, suggesting that axonal injury may occur early in the course of glucose intolerance. The American Diabetes Association (ADA) revised diagnostic criteria to recognize IGT (a serum glucose between 140 and 200 mg/dl in a 2-h oral glucose tolerance test [OGTT]) as a risk factor for cardiovascular disease independent of development of diabetes. RESEARCH DESIGN AND METHODS—Using revised ADA criteria for diabetes and IGT, we prospectively evaluated 107 sequential patients with idiopathic neuropathy. RESULTS—A total of 13 of the 107 patients had diabetes, whereas 36 (34%) had IGT, nearly three times the prevalence in age-matched control subjects (P < 0.01). OGTT was often elevated, whereas both fasting plasma glucose and HbA1c were normal. Comparing patients with diabetes, IGT, or normal OGTT, age and BMI were similar. However, painful sensory symptoms were more common in patients with IGT and diabetes, and family history of neuropathy was significantly more common in normoglycemic patients. Electrodiagnostic findings of axonal injury were less severe in patients with IGT and were more likely to be confined to sensory fibers than in patients with diabetes. CONCLUSIONS—Our results suggest that IGT may cause or contribute to small-fiber neuropathy, which is similar in phenotype to the painful sensory neuropathy commonly encountered in diabetes. Two-hour OGTT is more sensitive than other measures of glucose handling in screening these patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“There is controversy regarding the effect of glucose dysmetabolism on small nerve fibers34,42 and symptom severity16,48,56 in FMS.”
From Pain and small fiber pathology in men with fibromyalgia syndrome (2024) · cites this paper as [42]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Other forms of diabetic neuropathies are mononeuritis such as cranial nerve palsies or entrapment neuropathies (eg, carpal tunnel syndrome, ulnar entrapment, and peroneal entrapment, among others).632–635”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [635]
Experimental — accuracy not yet measuredIn the citing paper
“Finally, evidence is accumulating on increased prevalence of idiopathic polyneuropathy (eg, idiopathic sensory/painful neuropathy,73–78 and sensory/small fibre only neuropathy)73,75,78 among prediabetic individuals with IGT being more strongly related to painful than non-painful neuropathy.73,75,78”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [75]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,325
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1183 · Cited by 6,220
Harris, M. I., Flegal, K. M., Cowie, C. C., Eberhardt, M. S., Goldstein, D. E., Little, R. R., Wiedmeyer, H.-M., & Byrd-Holt, D. D. (1998) · Diabetes Care · doi:10.2337/diacare.21.4.518 · Cited by 2,703
Dyck, P. J., Kratz, K. M., Karnes, J. L., Litchy, W. J., Klein, R., Pach, J. M., Wilson, D. M., O'Brien, P. C., & Melton, L. J. (1993) · Neurology · doi:10.1212/wnl.43.4.817 · Cited by 1,482
Tominaga, M., Eguchi, H., Manaka, H., Igarashi, K., Kato, T., & Sekikawa, A. (1999) · Diabetes Care · doi:10.2337/diacare.22.6.920 · Cited by 1,165
(1999) · Diabetes Care · doi:10.2337/diacare.22.4.623 · Cited by 725
Brunzell, J. D., Robertson, R. P., Lerner, R. L., Hazzard, W. R., Ensinck, J. W., Bierman, E. L., & Porte, D. (1976) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-42-2-222 · Cited by 511
Periquet, M. I., Novak, V., Collins, M. P., Nagaraja, H. N., Erdem‐Özdamar, S., Nash, S. M., Freimer, M. L., Sahenk, Z., Kissel, J. T., & Mendell, J. R. (1999) · Neurology · doi:10.1212/wnl.53.8.1641 · Cited by 375
Barrett-Connor, E., & Ferrara, A. (1998) · Diabetes Care · doi:10.2337/diacare.21.8.1236 · Cited by 369 · cited 1×
“These results mirror large prospective studies in which results of OGTT in older patients are often consistent with diabetes but normal FPG (23), and asymptomatic patients with IGT have normal HbA1c (24).”
ResultSmall‐fiber sensory neuropathies: Clinical course and neuropathology of idiopathic cases
Holland, N. R., Crawford, T. O., Hauer, P. E., Cornblath, D. R., Griffin, J. W., & McArthur, J. C. (1998) · Annals of Neurology · doi:10.1002/ana.410440111 · Cited by 335
Intensive evaluation of referred unclassified neuropathies yields improved diagnosis
Dyck, P. J. B., Oviatt, K. F., & Lambert, E. H. (1981) · Annals of Neurology · doi:10.1002/ana.410100304 · Cited by 325
SENSORY NEUROPATHY IN NON-INSULIN-DEPENDENT DIABETES MELLITUS
Franklin, G. M., KAHN, L. B., Baxter, J. E., Marshall, J. A., & Hamman, R. F. (1990) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115547 · Cited by 281
Classification, Differential Diagnosis, and Staging of Diabetic Peripheral Neuropathy
Thomas, P. (1997) · Diabetes · doi:10.2337/diab.46.2.s54 · Cited by 281
The epidemiology of diabetic neuropathy
Ziegler, D., Gries, F. A., Spüler, M., & Lessmann, F. (1992) · Journal of Diabetes and its Complications · doi:10.1016/1056-8727(92)90049-q · Cited by 274
Evaluation of thermal and vibration sensation in diabetic neuropathy
Guy, R., Clark, C. A., Malcolm, P. N., & Watkins, P. (1985) · Diabetologia · doi:10.1007/bf00273859 · Cited by 223
Yudkin, J. S., Alberti, K. G. M. M., McLarty, D. G., & Swai, A. B. M. (1990) · BMJ · doi:10.1136/bmj.301.6749.397 · Cited by 191
Chronic Cryptogenic Sensory Polyneuropathy
Wolfe, G. I., Baker, N. S., Amato, A. A., Jackson, C. E., Nations, S., Saperstein, D., Choon, H., Katz, J., Bryan, W. W., & Barohn, R. J. (1999) · Archives of Neurology · doi:10.1001/archneur.56.5.540 · Cited by 148
Bonora, E., Kiechl, S., Oberhollenzer, F., Egger, G., Bonadonna, R. C., Muggeo, M., & Willeit, J. (2000) · Diabetologia · doi:10.1007/s001250050024 · Cited by 140
Dyck, P. J., Kratz, K. M., Karnes, J. L., Litchy, W. J., Klein, R., Pach, J. M., Wilson, D., OʼBrien, P. C., & Melton, L. J. (1993) · Cited by 138
Prevalence of Neuropathy in Newly Diagnosed NIDDM and Nondiabetic Control Subjects
Lehtinen, J. M., Uusitupa, M. I. J., Siitonen, O., & Pyörälä, K. (1989) · Diabetes · doi:10.2337/diab.38.10.1307 · Cited by 129
Fujimoto, W. Y., Bergstrom, R. W., Boyko, E. J., Kinyoun, J. L., Leonetti, D. L., Newell‐Morris, L. L., Robinson, L. R., Shuman, W. P., Stolov, W. C., Tsunehara, C. H., et al. (1994) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(94)90226-7 · Cited by 106
Cohen, J. A., Jeffers, B. W., Faldut, D., Marcoux, M., & Schrier, R. W. (1998) · Muscle & Nerve · doi:10.1002/(sici)1097-4598(199801)21:1 · Cited by 103
Little, R. R., England, J. D., Wiedmeyer, H.-M., McKenzie, E. M., Pettitt, D. J., Knowler, W. C., & Goldstein, D. E. (1988) · Diabetes · doi:10.2337/diab.37.1.60 · Cited by 90
DIABETIC NEUROPATHY PRESENTING AS THE INITIAL CLINICAL MANIFESTATION OF DIABETES
ELLENBERG, M. (1958) · Annals of Internal Medicine · doi:10.7326/0003-4819-49-3-620 · Cited by 80
Eriksson, K., Nilsson, H., Lindgärde, F., Österlin, S. E., Dahlin, L. B., Lilja, B., Rosén, I., & Sundkvist, G. (1994) · Diabetic Medicine · doi:10.1111/j.1464-5491.1994.tb00272.x · Cited by 64
Impaired glucose tolerance. Why is it not a disease?
Perry, R., & Baron, A. (1999) · Diabetes Care · doi:10.2337/diacare.22.6.883 · Cited by 63
From Diagnosis and Classification to Complications and Therapy: DCCT Part II?
Orchard, T. J. (1994) · Diabetes Care · doi:10.2337/diacare.17.4.326 · Cited by 60
Prevalence of neuropathy in newly diagnosed NIDDM and nondiabetic control subjects
Lehtinen, J. M., Uusitupa, M. I. J., Siitonen, O., et al. (1989) · Diabetes · doi:10.2337/diabetes.38.10.1307 · Cited by 57
Predictors of early disease in the lower limbs.
Dormandy, J., Heeck, L., & Vig, S. (1999) · PubMed · Cited by 50
Cryptogenic Sensory and Sensorimotor Polyneuropathies
Wolfe, G. I., & Barohn, R. J. (1998) · Seminars in Neurology · doi:10.1055/s-2008-1040866 · Cited by 46
Boulton, A. J. M. (1992) · Journal of Diabetes and its Complications · doi:10.1016/1056-8727(92)90050-u · Cited by 42
Little, R. R., England, J. D., Wiedmeyer, H.-M., et al. (1988) · Diabetes · doi:10.2337/diabetes.37.1.60 · Cited by 30
Neuropatia vegetativa em pacientes com tolerância diminuída à glicose
Rezende, K. F., Melo, A. D. S., Pousada, J. M. D. C., Resende, Z. F., Santos, N. L., & Gomes, I. (1997) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x1997000500005 · Cited by 14
[Neurological disorders associated with impaired glucose tolerance].
Suzuki, K. (1996) · PubMed · Cited by 4
Cited by
Sorted by citations
Prediabetes: a high-risk state for diabetes development
Tabák, A. G., Herder, C., Rathmann, W., Brunner, E. J., & Kivimäki, M. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60283-9 · Cited by 2,958
Diabetic neuropathy: A position statement by the American Diabetes Association
Pop-Busui, R., Boulton, A. J. M., Feldman, E. L., Bril, V., Freeman, R., Malik, R. A., Sosenko, J. M., & Ziegler, D. (2017) · Diabetes Care · doi:10.2337/dc16-2042 · Cited by 2,602
Vinik, A. I., Maser, R. E., Mitchell, B. D., & Freeman, R. (2003) · Diabetes Care · doi:10.2337/diacare.26.5.1553 · Cited by 2,044
Diabetic neuropathy: clinical manifestations and current treatments
Callaghan, B. C., Cheng, H. T., Stables, C. L., Smith, A. L., & Feldman, E. L. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70065-0 · Cited by 1,271
Self-citationThe spectrum of neuropathy in diabetes and impaired glucose tolerance
Sumner, C. J., Sheth, S., Griffin, J. W., Cornblath, D. R., & Polydefkis, M. (2003) · Neurology · doi:10.1212/wnl.60.1.108 · Cited by 708
Metadata
- Authors
- Singleton, J. R., Smith, A. G., & Bromberg, M. B.
- Affiliations
- University of Utah (US)
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2001-08-01
- Volume
- 24
- Issue
- 8
- Pages
- 1448-1453
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2095995150
- Cited by
- 364
- References
- 32
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 9 · 2023: 7 · 2022: 12 · 2021: 7 · 2020: 21 · 2019: 9 · 2018: 17 · 2017: 20 · 2016: 14 · 2015: 22 · 2014: 28 · 2013: 25 · 2012: 21
- FWCI
- 4.72
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Keywords
- impaired glucose tolerance, small fiber neuropathy, peripheral neuropathy, diabetes mellitus, oral glucose tolerance test, axonal injury, electrodiagnostic findings
- MeSH terms
- Adult, Aged, Arsenic, Blood Glucose, Cardiovascular Diseases, Diabetic Neuropathies, Electromyography, Glucose Tolerance Test, Glycated Hemoglobin, Humans, Lead, Mercury, Middle Aged, Neural Conduction, Neuralgia, Peripheral Nervous System Diseases, Prospective Studies, Risk Factors, Body Mass Index, Prevalence, Glucose Intolerance
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
